[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336547-105":59,"doc-detail-336547-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prediction-of-metabolites-associated-with-somatic-mutations-in-cancers-by-using-genome-scale-metabolic-models-and-mutation-data","Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data","","Metabolic reprogramming drives cancer progression, and oncometabolites—metabolites generated by gene mutations that accumulate abnormally—represent promising therapeutic leads. Identifying mutation-associated metabolites is difficult because cells contain many metabolites and numerous cancer-linked genes. The study introduces a computational workflow to predict metabolite-gene-pathway sets using cancer patient-specific genome-scale metabolic models and mutation data, then validates results with multi-omics data and comparisons across multiple cancer types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prediction-of-metabolites-associated-with-somatic-mutations-in-cancers-by-using-genome-scale-metabolic-models-and-mutation-data/336547/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prediction-of-metabolites-associated-with-somatic-mutations-in-cancers-by-using-genome-scale-metabolic-models-and-mutation-data/336547.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What computational workflow is developed in the study?","Question",{"text":112,"@type":113},"A workflow that predicts metabolite-gene-pathway sets, using both cancer patient-specific genome-scale metabolic models and mutation data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are the predicted metabolite-gene relationships validated?",{"text":117,"@type":113},"By comparing resulting metabolite-gene pairs with multi-omics data (mutation data, RNA-seq data, and metabolome data) from acute myeloid leukemia and renal cell carcinoma samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main conclusion about the predicted sets?",{"text":121,"@type":113},"Validation indicates a meaningful number of metabolites and metabolic pathways are significantly associated with specific somatic mutations, supporting discovery of novel oncometabolites and potential cancer treatment strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336547,1790019746,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Lee et al. Genome Biology (2024) 25:66  \n[https://doi.org/10.1186/s13059-024-03208-8](https://doi.org/10.1186/s13059-024-03208-8)  \nGenome Biology  \nRESEARCH Open Access  \nPrediction of metabolites associated  \nwith somatic mutations in cancers by using genome-scale metabolic models and mutation data  \nGaRyoung Lee1,2†, Sang Mi Lee1,2†, Sungyoung Lee3, Chang Wook Jeong4, Hyojin Song3, Sang Yup Lee 1,2,5, Hongseok Yun3*, Youngil Koh6* and Hyun Uk Kim1,2,5*  \n\n| †GaRyoung Lee and Sang Mi Lee contributed equally to this work. |\n| --- |\n| *Correspondence:\u003Cbr>[hsyun@snuh.org](hsyun@snuh.org); go01@snu. [ac.kr](ac.kr); [ehukim@kaist.ac.kr](ehukim@kaist.ac.kr) |\n\n1 Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea  \n2 Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, KAIST, Daejeon 34141, Republic of Korea  \n3 Department of Genomic Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea  \n4 Department of Urology, Seoul National University College of Medicine, and Seoul National University Hospital, Seoul 03080, Republic of Korea  \n5 Graduate School of Engineering Biology, BioProcess Engineering Research Center, and BioInformatics Research Center, KAIST, Daejeon 34141, Republic of Korea  \n6 Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea  \nAbstract  \nBackground: Oncometabolites, often generated as a result of a gene mutation, show pro-oncogenic function when abnormally accumulated in cancer cells. Identification of such mutation-associated metabolites will facilitate developing treatment strategies for cancers, but is challenging due to the large number of metabolites in a cell and the presence of multiple genes associated with cancer development.  \nResults: Here we report the development of a computational workflow that predicts metabolite-gene-pathway sets. Metabolite-gene-pathway sets present metabolites and metabolic pathways significantly associated with specific somatic mutations in cancers. The computational workflow uses both cancer patient-specific genomescale metabolic models (GEMs) and mutation data to generate metabolite-gene-pathway sets. A GEM is a computational model that predicts reaction fluxes at a genome scale and can be constructed in a cell-specific manner by using omics data. The computational workflow is first validated by comparing the resulting metabolite-gene pairs with multi-omics data (i. e., mutation data, RNA-seq data, and metabolome data) from acute myeloid leukemia and renal cell carcinoma samples collected in this study. The computational workflow is further validated by evaluating the metabolite-genepathway sets predicted for 18 cancer types, by using RNA-seq data publicly available, in comparison with the reported studies. Therapeutic potential of the resulting metabolite-gene-pathway sets is also discussed.  \nConclusions: Validation of the metabolite-gene-pathway set-predicting computational workflow indicates that a decent number of metabolites and metabolic pathways appear to be significantly associated with specific somatic mutations. The computational workflow and the resulting metabolite-gene-pathway sets will help identify novel oncometabolites and also suggest cancer treatment strategies.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s C","cbCaid0GBsxyC3PS","https://ap.wps.com/l/cbCaid0GBsxyC3PS","pdf",10402541,26,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Keywords\n## Background","[{\"question\":\"What computational workflow is developed in the study?\",\"answer\":\"A workflow that predicts metabolite-gene-pathway sets, using both cancer patient-specific genome-scale metabolic models and mutation data.\"},{\"question\":\"How are the predicted metabolite-gene relationships validated?\",\"answer\":\"By comparing resulting metabolite-gene pairs with multi-omics data (mutation data, RNA-seq data, and metabolome data) from acute myeloid leukemia and renal cell carcinoma samples.\"},{\"question\":\"What is the main conclusion about the predicted sets?\",\"answer\":\"Validation indicates a meaningful number of metabolites and metabolic pathways are significantly associated with specific somatic mutations, supporting discovery of novel oncometabolites and potential cancer treatment strategies.\"}]","Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data | PDF",1790015558,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d993c93802d072b60af575a7015b95f3.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aad96ae0163f61b47d217d36a9325506.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a57d2f1c85f9593dbf5ab11196f80618.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d305353216f57b3e59d83d4427802f2.webp",980,1301]